Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management

Madison Simons*, Tiffany H. Taft

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1151-1152
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume53
Issue number10
DOIs
StatePublished - May 2021

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this